News Releases
Previous All pages Next 1 2 3 4 Page 5 6 7 8 9
January 08, 2007  Award Winning Harvard Diabetes Specialist Appointed to Help Advance Sernova's Sertolin Diabetes Therapy to Clinical Trials
December 19, 2006  Results of Toronto Hospital Study of Diabetic Mice Supports Sernova Corp's Cellular Therapy Technology
December 04, 2006  Leading Virologist Dr. Clive Patience Appointed to Help Guide the Development of Sernova's Proposed Diabetes Product
December 01, 2006  Breakthrough Magnetic Resonance Imaging Technique Developed for Diabetes's Cellular Therapy: Published in November Issue of Medical Journal, "Diabetes"
October 23, 2006  Sernova's Research Following Latest NIH Guidelines for Type 1 Diabetes
October 02, 2006  Sernova's Sertoli Cell Research Hopes to Replace Anti-Rejection Drugs in Edmonton Protocol Islet Transplants for Diabetics
September 25, 2006  Dr. George Adams Appointed to Board of Directors to Help Commercialize Insulin Dependent Diabetes Product
September 20, 2006  Diabetic Product Development Leads to Name Change: Sernova Corp.
August 01, 2006  Pheromone Builds Scientific Advisory Board: Sertoli Cell Expert Dr. Jannette Dufour to Help Develop Diabetes Product
July 28, 2006  Business Advisory Board Established to Commercialize Diabetes Product
Previous All pages Next 1 2 3 4 Page 5 6 7 8 9